Web Analytics

3 Latest Announced Rounds

  • $10,600,000
    Pre-Seed

    5 Investors

    Technology, Information and Internet
    Jun 6th, 2025
  • $13,702,071
    Series A

    3 Investors

    Insurance
    Jun 6th, 2025
  • $15,000,000
    Unknown

    1 Investors

    Biotechnology Research
    Jun 6th, 2025
$863.23M Raised in 46 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Indapta Therapeutics

start up
United States - Seattle & Houston
  • 18/12/2024
  • Unknown
  • $22,500,000

Indapta's allogeneic g-NK cells have highly potent ADCC activity, making them the ideal therapy to combine with IgG1 monoclonal antibodies, ADCs, or innate immune cell engager molecules.


Related People

Mark FrohlichFounder

Mark Frohlich United States - Greater Seattle Area

N/A